Fibromyalgia vs Lupus: Symptoms, Diagnosis, and Key Differences

Fibromyalgia is a disorder of central pain processing that does not damage organs, while lupus (systemic lupus erythematosus, or SLE) is an autoimmune disease in which the immune system attacks the joints, skin, kidneys, blood cells and other tissues. The most reliable way to tell them apart is objective evidence: lupus usually shows a positive ANA plus findings such as joint swelling, a rash, low complement or protein in the urine, while fibromyalgia produces widespread pain with normal blood work and a normal examination.

Here is a scenario that plays out in rheumatology clinics every day: a patient walks in with widespread pain, crushing fatigue, joint stiffness, and brain fog. The question on everyone’s mind is whether this is fibromyalgia, lupus, or possibly both. The distinction matters enormously because these two conditions require very different treatment approaches, and getting it wrong can mean years of ineffective therapy.

Fibromyalgia is a disorder of central pain processing. Lupus (systemic lupus erythematosus, or SLE) is an autoimmune disease in which the immune system attacks the body’s own tissues. One involves a nervous system that amplifies pain signals. The other involves immune-mediated inflammation that can damage organs. Understanding the difference starts with recognizing where these conditions overlap and where they diverge.

Symptoms That Overlap

The reason these conditions are so frequently confused is that they share a substantial list of symptoms. Both can produce:

• Widespread musculoskeletal pain
• Severe fatigue that does not improve with rest
• Cognitive difficulties (“brain fog”)
• Sleep disturbances
• Morning stiffness
• Headaches
• Mood disorders (depression, anxiety)
• Sensitivity to weather changes

If you only look at the symptom list, these two conditions can appear nearly identical. The differences emerge when you dig into the nature of those symptoms, the physical examination, and the laboratory findings.

Symptoms that lean toward fibromyalgia

Fibromyalgia pain is typically described as a deep ache or burning that moves around the body, with tenderness to light pressure (allodynia) and an exaggerated response to painful stimuli (hyperalgesia). It often travels with conditions that share the same sensitized nervous system, including irritable bowel syndrome, tension and migraine headaches, jaw pain from temporomandibular joint disorder, and unrefreshing sleep. Cognitive symptoms, often called fibro fog, are covered in depth in our piece on why fibromyalgia brain fog happens.

Symptoms that lean toward lupus

Lupus symptoms tend to be visible or measurable. A facial rash across the cheeks and nose after sun exposure, painless mouth or nose sores, patchy hair loss, chest pain when breathing deeply (pleurisy), swelling in the legs from kidney involvement, and recurring low-grade fevers all point toward an inflammatory process rather than pain amplification. Any one of these deserves an autoimmune workup, even when fatigue and aching are the main complaints.

Key Distinguishing Features

Feature	Fibromyalgia	Lupus (SLE)
Type of pain	Diffuse, aching, “everywhere,” tender points	Joint-specific (often hands, wrists, knees), may involve visible swelling
Joint swelling	Absent (pain without inflammation)	Often present, especially in small joints of hands and feet
Skin findings	None specific to the condition	Butterfly (malar) rash, discoid rash, photosensitivity, oral ulcers
Organ involvement	None (does not damage organs)	Can affect kidneys, heart, lungs, brain, blood cells
Fever	Not typical	Low-grade fevers are common during flares
Hair loss	Not a feature	Common, often diffuse or at the hairline
Raynaud’s phenomenon	Can occur but is not central to the condition	Present in about 30-40% of lupus patients
Blood test abnormalities	Typically normal	Positive ANA, anti-dsDNA, low complement, cytopenias
Inflammatory markers (ESR, CRP)	Usually normal	Often elevated during active disease

The pattern in the table comes down to one rule. Lupus leaves objective traces, such as swollen joints, rashes, abnormal urine and abnormal blood counts, while fibromyalgia produces real and often severe pain without those traces. A clinician who finds none of the lupus features in the right column, on examination and on repeat testing, has strong grounds to diagnose fibromyalgia rather than early lupus.

The Diagnostic Workup: Blood Tests That Matter

When your doctor suspects either condition, blood work is the first step in separating them. Here are the key tests and what they tell you:

ANA (Antinuclear Antibody)

ANA is the primary screening test for lupus. About 97% of lupus patients test positive. However, a positive ANA alone does not confirm lupus. Roughly 15-20% of healthy individuals (and even more among older adults) will test positive. A negative ANA, on the other hand, makes lupus very unlikely. Fibromyalgia patients occasionally have low-titer positive ANA results, which can create confusion. Context matters.

Anti-dsDNA (Anti-double-stranded DNA)

This antibody is highly specific to lupus. When positive, it strongly supports an SLE diagnosis. It also correlates with disease activity, particularly kidney involvement. Fibromyalgia does not produce anti-dsDNA antibodies.

Anti-Smith Antibodies

Another lupus-specific antibody. Less commonly tested than anti-dsDNA but very specific when positive. If anti-Smith is positive, the diagnosis is almost certainly lupus.

Complement Levels (C3, C4)

In active lupus, complement proteins are consumed as the immune system attacks the body’s own tissues, so C3 and C4 levels drop. Low complement combined with positive anti-dsDNA is a classic lupus pattern. Fibromyalgia does not affect complement levels.

CBC (Complete Blood Count)

Lupus commonly causes low white blood cells (leukopenia), low platelets (thrombocytopenia), or anemia. These findings on a routine blood count should trigger further investigation for lupus. Fibromyalgia does not cause blood count abnormalities.

ESR and CRP

These general markers of inflammation are usually normal in fibromyalgia and elevated in active lupus. A persistently normal ESR and CRP in someone with widespread pain points away from lupus and toward fibromyalgia.

Urinalysis and kidney function

A urinalysis checks for protein, blood and cellular casts in the urine, which are early signs of lupus nephritis, the kidney inflammation that affects a significant share of people with SLE. A basic metabolic panel adds creatinine to estimate kidney function. Kidney involvement often causes no pain at first, which is why a routine urine test belongs in every workup for unexplained widespread pain and fatigue. Fibromyalgia does not affect the urine or the kidneys.

Tests that rule out other causes

Clinicians usually add thyroid stimulating hormone (TSH), because hypothyroidism causes fatigue, aching and brain fog, plus a metabolic panel, vitamin D, and sometimes creatine kinase to look for muscle inflammation. Rheumatoid factor and anti-CCP antibodies help separate lupus from rheumatoid arthritis when the hands and wrists are involved. Normal results across this panel are part of how fibromyalgia is confirmed.

How Doctors Diagnose Fibromyalgia and Lupus: The Official Criteria

Fibromyalgia and lupus are confirmed with two very different rule sets. Fibromyalgia criteria score symptoms the patient reports and the doctor confirms, while lupus criteria require laboratory and clinical evidence of autoimmunity. Knowing which rule set applies explains why one condition can be diagnosed with normal labs and the other cannot.

The 2016 ACR fibromyalgia criteria

The 2016 revision of the American College of Rheumatology fibromyalgia criteria, published by Frederick Wolfe and colleagues in Seminars in Arthritis and Rheumatism (2016), replaced the older 1990 tender point exam. It scores pain across 19 body areas (the widespread pain index, or WPI) and the severity of fatigue, unrefreshing sleep and cognitive symptoms (the symptom severity scale, or SSS). A diagnosis needs a WPI of 7 or more with an SSS of 5 or more, or a WPI of 4 to 6 with an SSS of 9 or more, plus generalized pain in at least 4 of 5 regions for at least 3 months.

The same revision states that a fibromyalgia diagnosis is valid irrespective of other diagnoses. That sentence matters for this comparison, because it means a person with confirmed lupus can also be diagnosed with fibromyalgia rather than having every symptom credited to lupus.

The 2019 EULAR/ACR lupus criteria

The 2019 European League Against Rheumatism and American College of Rheumatology (EULAR/ACR) classification criteria for SLE, led by Martin Aringer and published in Arthritis & Rheumatology (2019), start with a required entry criterion: a positive ANA at a titer of at least 1:80. Findings are then weighted from 2 to 10 points across seven clinical domains (constitutional, hematologic, neuropsychiatric, mucocutaneous, serosal, musculoskeletal and renal) and three immunologic domains (antiphospholipid antibodies, complement proteins and SLE-specific antibodies). A total of 10 points or more, with at least one clinical criterion, classifies SLE.

In the validation cohort, these criteria showed a sensitivity of 96.1% and a specificity of 93.4%, according to Aringer and colleagues. They were designed for research classification, so rheumatologists use them as a framework while still applying clinical judgment to the individual patient.

Diagnostic element	Fibromyalgia (ACR 2016)	Lupus (EULAR/ACR 2019)
Entry requirement	Generalized pain in at least 4 of 5 regions	ANA titer of at least 1:80
Scoring method	WPI and symptom severity scale	Weighted domains, 10 points or more
Minimum duration	Symptoms present for at least 3 months	No fixed duration; criteria can accumulate over time
Role of blood tests	Used to rule out other conditions	Required to classify the disease
Coexisting diagnoses	Valid regardless of other diagnoses	Other explanations must be judged less likely

Can You Have Both Fibromyalgia and Lupus?

Absolutely, and this is more common than many patients realize. Studies consistently show that 20-30% of lupus patients also meet diagnostic criteria for fibromyalgia. This creates a challenging clinical picture because when a lupus patient develops worsening pain and fatigue, the question becomes: is this a lupus flare requiring increased immunosuppression, or is it fibromyalgia requiring a completely different approach?

Getting this distinction right is critical. Increasing immunosuppressive therapy for what is actually fibromyalgia pain exposes the patient to unnecessary drug side effects without improving their symptoms. Conversely, attributing new symptoms to fibromyalgia when lupus is actually flaring can allow organ damage to progress unchecked.

The clues that point toward a lupus flare rather than fibromyalgia in a patient who has both:

• New or worsening joint swelling (not just pain)
• New rashes or skin changes
• Falling complement levels on blood work
• Rising anti-dsDNA titers
• New protein or blood in the urine
• Elevated ESR or CRP
• Fever

If none of these are present, the worsening symptoms are more likely fibromyalgia-driven.

Researchers think chronic inflammation, persistent pain, poor sleep and the stress of living with a serious illness can sensitize the central nervous system over time, which may explain why fibromyalgia shows up so often alongside lupus, rheumatoid arthritis and other autoimmune diseases. In that setting it is sometimes called secondary or concomitant fibromyalgia. The fibromyalgia component can persist even when lupus activity is well controlled, which is why lab results and symptoms need to be read together.

Other Conditions That Look Like Fibromyalgia or Lupus

Widespread pain and fatigue have a long list of possible causes, and a careful workup checks for the common ones before settling on either diagnosis. These conditions overlap most often with fibromyalgia and lupus:

• Hypothyroidism and Hashimoto’s thyroiditis: fatigue, aching muscles, weight change and slowed thinking, picked up with a TSH test and thyroid antibodies.
• Rheumatoid arthritis: symmetric swelling of the small hand joints with rheumatoid factor or anti-CCP antibodies, covered in our overview of rheumatoid arthritis causes and treatment.
• Sjögren’s disease: dry eyes and dry mouth with anti-SSA and anti-SSB antibodies, and it can coexist with lupus.
• Polymyalgia rheumatica: shoulder and hip girdle stiffness in adults over 50 with high ESR or CRP.
• Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): profound fatigue that worsens after exertion, described on our chronic fatigue syndrome page.
• Drug-induced lupus: lupus-like symptoms triggered by medications such as hydralazine, procainamide, isoniazid or TNF inhibitors, often with anti-histone antibodies, which usually settles after the drug is stopped.
• Long COVID and post-viral syndromes: fatigue, brain fog and body pain after an infection, discussed on our long COVID condition page.

A clinician who rules these out, and finds no objective signs of lupus, is on firm ground diagnosing fibromyalgia. Our article on feeling sick when blood work is normal covers what to ask for next when standard labs come back clean.

Treatment Differences

The treatment approaches for these two conditions differ fundamentally because the underlying disease mechanisms are entirely different.

Lupus Treatment

Lupus treatment targets the overactive immune system. The standard toolkit includes:

• Hydroxychloroquine (Plaquenil): The foundation of lupus treatment. Nearly all lupus patients should be on this medication. It reduces flares, protects organs, and improves survival.
• Corticosteroids: Prednisone and similar drugs control acute flares but carry significant long-term side effects.
• Immunosuppressants: Mycophenolate, azathioprine, methotrexate, and others are used for more severe disease, particularly when the kidneys or other organs are involved.
• Biologics: Belimumab (Benlysta) and anifrolumab (Saphnelo) target specific immune pathways in lupus.
• Sun protection: UV light triggers lupus flares. Rigorous sun protection is a medical necessity, not just cosmetic advice.

Lupus care is led by a rheumatologist, often with a nephrologist when the kidneys are involved and a dermatologist for cutaneous lupus. People taking hydroxychloroquine need regular eye exams to screen for retinal toxicity, and anyone on long-term steroids or immunosuppressants needs routine blood monitoring.

Fibromyalgia Treatment

Fibromyalgia treatment targets the nervous system and pain processing. Immunosuppressive drugs do not help. The approach includes:

• Medications: Duloxetine (Cymbalta), milnacipran (Savella), pregabalin (Lyrica), and low-dose naltrexone work through different mechanisms to reduce central sensitization.
• Exercise: Regular, graded aerobic exercise is one of the most effective interventions for fibromyalgia. It must be started slowly and increased gradually.
• Sleep optimization: Addressing sleep disorders (particularly sleep apnea and restless legs syndrome) can dramatically improve fibromyalgia symptoms.
• Cognitive behavioral therapy: CBT helps patients develop coping strategies and can reduce the psychological amplification of pain signals.
• Integrative therapies: Acupuncture, tai chi, yoga, and mindfulness meditation all have evidence supporting their use in fibromyalgia.

Duloxetine, milnacipran and pregabalin are the three drugs the FDA has approved for fibromyalgia. Low-dose naltrexone (LDN) is used off label, usually at 4.5 mg daily, and its evidence is mixed: a small crossover trial of 31 women by Jarred Younger and colleagues in Arthritis & Rheumatism (2013) found a greater drop in daily pain than placebo, while a 58 patient crossover trial by Bested and colleagues in Pain Reports (2023) found no clinically relevant benefit. Our review of LDN for fibromyalgia covers dosing and side effects in more detail.

Integrative and regenerative options for fibromyalgia

Some people with fibromyalgia look beyond standard care to cash pay options such as hyperbaric oxygen therapy (HBOT), ketamine infusions or IV nutrient therapy. The evidence here is thin. The most cited HBOT study, a prospective crossover trial of 60 women by Shai Efrati and colleagues in PLoS One (2015), reported symptom improvement and changes on brain imaging, but it was small and had no sham control group, and HBOT is not FDA cleared for fibromyalgia. The fibromyalgia treatment guide compares these options, and the hyperbaric oxygen therapy overview explains how HBOT works and what a course of treatment involves.

If you want to see who offers it, the national directory of hyperbaric oxygen therapy clinics lists providers by state and city. Listing order is not paid ranking, Featured slots are labeled and capped, Verified means credential checks rather than spend, and Regenerated.com is free for patients. Inclusion in the directory is not an endorsement, so confirm that any clinic coordinates with your rheumatologist, especially if you also have lupus. None of these options replaces immunosuppressive treatment for lupus.

Treatment area	Lupus (SLE)	Fibromyalgia
Main target	Overactive immune system	Central pain processing and sleep
FDA approved drugs	Hydroxychloroquine, corticosteroids, belimumab, anifrolumab	Pregabalin, duloxetine, milnacipran
Common off label options	Mycophenolate, azathioprine, methotrexate	Low-dose naltrexone, amitriptyline, cyclobenzaprine
Core non-drug care	Sun protection, regular lab and eye monitoring	Graded aerobic exercise, CBT, sleep treatment
Lead clinician	Rheumatologist	Rheumatologist, primary care physician or pain specialist

When to See a Rheumatologist

You should see a rheumatologist if you have any of the following alongside your pain and fatigue:

• Visible joint swelling
• Unexplained rashes, especially on the face or after sun exposure
• Positive ANA or other autoimmune markers
• Unexplained anemia, low white count, or low platelets
• Protein or blood in the urine
• Recurrent oral ulcers
• Raynaud’s phenomenon (fingers turning white or blue in the cold)
• Unexplained fevers

A rheumatologist can perform the detailed evaluation needed to distinguish between fibromyalgia and lupus, diagnose both if they coexist, and create a treatment plan that addresses the right condition with the right tools.

According to the CDC’s lupus overview, there is no single test for lupus, and diagnosis rests on a discussion of symptoms, a physical exam and lab tests. Bring a written symptom timeline, photos of any rashes or swelling taken when they appear, and copies of earlier lab results to the first visit, since lupus findings can come and go between appointments.

The Diagnostic Journey: Why Misdiagnosis Is Common

The average lupus patient sees four doctors over four years before receiving a correct diagnosis. Fibromyalgia patients often face a similar timeline. Part of the problem is that both conditions can present gradually, with symptoms accumulating over months or years before the full picture becomes clear.

Several patterns of misdiagnosis are especially common:

• Fibromyalgia diagnosed as early lupus: A patient with widespread pain gets an ANA test, which comes back weakly positive. The doctor assumes lupus and starts hydroxychloroquine or even prednisone. The patient does not improve because the underlying problem is central sensitization, not autoimmunity. Meanwhile, the correct diagnosis is delayed.
• Lupus misdiagnosed as fibromyalgia: A patient presents with pain and fatigue. Autoimmune blood work is not ordered because the symptoms sound like fibromyalgia. Months later, the patient develops kidney involvement or severe joint swelling, and lupus is finally diagnosed after organ damage has already occurred.
• Both conditions present, but only one is recognized: A lupus patient develops secondary fibromyalgia, but every symptom gets attributed to lupus. Immunosuppressive doses keep getting increased for symptoms that are actually driven by central sensitization, not inflammation.

The lesson here is that a thorough workup matters. Any patient presenting with widespread pain and fatigue should have basic autoimmune labs drawn (ANA, CBC, ESR, CRP, urinalysis) before settling on a diagnosis of fibromyalgia. And any lupus patient whose pain seems disproportionate to their inflammatory markers should be evaluated for concurrent fibromyalgia.

Living with a Dual Diagnosis

For patients who have both lupus and fibromyalgia, treatment planning requires careful coordination. The lupus component needs immunosuppressive management, regular lab monitoring, and sun protection. The fibromyalgia component needs nervous system-targeted therapies, sleep optimization, exercise, and potentially medications like duloxetine or pregabalin. Neither treatment plan alone addresses both conditions.

It also means learning to distinguish your own flare patterns. Over time, many patients learn to recognize the difference between a lupus flare (fever, new rash, joint swelling, that specific heavy feeling of systemic inflammation) and a fibro flare (diffuse pain amplification, extreme fatigue, cognitive fog without the inflammatory symptoms). That self-awareness becomes a valuable clinical tool for guiding treatment decisions with your rheumatologist.

A simple symptom diary that records pain, fatigue, sleep, sun exposure, stress and any rash or swelling makes those patterns visible to you and your care team. Our guide to managing a fibromyalgia flare-up covers pacing and recovery, and the chronic pain condition page links to related treatment options. When symptoms limit work, the article on fibromyalgia and disability benefits explains how documentation from both conditions is handled.

The Bottom Line

Fibromyalgia and lupus may look similar on the surface, but they are fundamentally different diseases requiring fundamentally different treatments. The key differentiators are objective findings: joint swelling, skin rashes, organ involvement, and abnormal blood tests (particularly anti-dsDNA, complement levels, and CBC abnormalities) all point toward lupus. Widespread pain without these objective findings, normal bloodwork, and pain that is disproportionate to any visible pathology points toward fibromyalgia. And if you have both, working with a clinician who recognizes the overlap is essential for getting the right treatment for the right problem at the right time.

Related Reading

• Fibromyalgia: The Complete Guide to Symptoms, Causes, and Treatment
• Rheumatoid Arthritis: Causes, Symptoms, and Modern Treatment
• Fibromyalgia Brain Fog (Fibro Fog): Why It Happens and What Helps
• Fibromyalgia and Disability: Qualification, Documentation, and Benefits

Frequently Asked Questions

What is the core difference between fibromyalgia and lupus?

Fibromyalgia is a disorder of central pain processing, while lupus (systemic lupus erythematosus, or SLE) is an autoimmune disease in which the immune system attacks the body’s own tissues. Lupus can produce measurable pathology such as a butterfly (malar) rash, oral ulcers, low complement and organ involvement affecting the kidneys, heart, lungs, brain or blood cells. Fibromyalgia causes real, often severe pain but has no specific lab findings and does not damage organs.

Can you have both fibromyalgia and lupus at the same time?

Yes. Studies consistently show that 20 to 30 percent of lupus patients also meet the diagnostic criteria for fibromyalgia, and the 2016 ACR criteria state that fibromyalgia can be diagnosed alongside other conditions. When both are present, new joint swelling, new rashes, falling complement, rising anti-dsDNA, protein or blood in the urine, elevated ESR or CRP, and fever point to a lupus flare rather than a fibromyalgia flare.

Does a positive ANA blood test mean I have lupus?

No, a positive ANA on its own does not mean lupus. About 97 percent of lupus patients test positive for antinuclear antibody (ANA), but so do roughly 15 to 20 percent of healthy individuals, and even more older adults. A positive ANA with normal anti-dsDNA, normal complement, a normal CBC and normal inflammatory markers points away from lupus. A negative ANA makes lupus very unlikely.

Which blood tests actually distinguish lupus from fibromyalgia?

Anti-dsDNA and anti-Smith antibodies are the most lupus-specific tests, and anti-dsDNA also tracks disease activity and kidney involvement. Low C3 and C4 complement combined with positive anti-dsDNA is a classic lupus pattern. Lupus can also cause low white cells, low platelets, anemia, protein in the urine and raised ESR or CRP. In fibromyalgia, all of these results are usually normal.

How are the two conditions treated differently?

Lupus treatment targets the immune system, with hydroxychloroquine (Plaquenil) as the foundation for nearly all patients, plus corticosteroids, immunosuppressants, biologics like belimumab and anifrolumab, and rigorous sun protection. Fibromyalgia treatment targets the nervous system with duloxetine, milnacipran or pregabalin, sometimes off label low-dose naltrexone, along with graded aerobic exercise, sleep treatment and cognitive behavioral therapy. Immunosuppressive drugs do not help fibromyalgia.

Why does it take so long to get the right diagnosis?

The average lupus patient sees four doctors over four years before receiving a correct diagnosis, and fibromyalgia patients often face a similar timeline. Misdiagnosis usually happens in three ways: fibromyalgia labeled as early lupus because of a weakly positive ANA alone, lupus missed and called fibromyalgia while organ damage progresses, and both conditions present but only one recognized, which leads to the wrong treatment being escalated.